Copertina

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Annals of Clinical and Translational Neurology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Performance of Composite Endpoints Defining Progression Independent of Relapse Activity in Multiple Sclerosis
di: Ludwig Kappos, et al.
Pubblicazione: (2025)

Reply to “New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond”
di: Joseph J. Sabatino, et al.
Pubblicazione: (2025)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
di: Massimiliano Calabrese, et al.
Pubblicazione: (2024)

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence
di: Gabriel Cerono, et al.
Pubblicazione: (2025)

Relapse‐Associated and Relapse‐Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different Eras
di: Noemi Montobbio, et al.
Pubblicazione: (2024)

A Patient‐Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis
di: Chad Smith, et al.
Pubblicazione: (2026)

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis
di: Tomas Uher, et al.
Pubblicazione: (2025)

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review
di: Patricia K. Coyle, et al.
Pubblicazione: (2024)

Correction to “Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD ?”
Pubblicazione: (2024)

Efficacy of Inebilizumab in N‐ MOmentum Trial Participants With or Without Prior Immunosuppressants
di: Bruce A. C. Cree, et al.
Pubblicazione: (2026)

High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis
di: Simone Sacco, et al.
Pubblicazione: (2025)

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis
di: Ali Manouchehrinia, et al.
Pubblicazione: (2025)

Relapses, Comorbidities, and Predictors of Outcome in Anti‐ GABA A Receptor Encephalitis
di: Claudia Papi, et al.
Pubblicazione: (2026)

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
di: F. Shawket, et al.
Pubblicazione: (2026)

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
di: Gary Birnbaum
Pubblicazione: (2025)

Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Automated and Interpretable Detection of Hippocampal Sclerosis in Temporal Lobe Epilepsy: AID ‐ HS
di: Mathilde Ripart, et al.
Pubblicazione: (2024)

Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis
di: Wallace J. Brownlee, et al.
Pubblicazione: (2024)

Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study
di: Fatema Alzamanan, et al.
Pubblicazione: (2024)

Hospital‐Treated Infections and Risk of Disability Worsening in Multiple Sclerosis
di: Yihan Hu, et al.
Pubblicazione: (2024)

Wine Glass Sign in Bulbar Onset Amyotrophic Lateral Sclerosis
di: Prashant Bhatele, et al.
Pubblicazione: (2024)

Letter on Wine Glass Sign in Bulbar‐Onset Amyotrophic Lateral Sclerosis
di: Yu Zhu, et al.
Pubblicazione: (2025)

Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
di: Monica Margoni, et al.
Pubblicazione: (2024)

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients
di: Matthew R. Brier, et al.
Pubblicazione: (2024)

The Scientific and Therapeutic Rationale for Off‐Label Treatments in Amyotrophic Lateral Sclerosis
di: Richard Bedlack, et al.
Pubblicazione: (2024)

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study
di: Dimitrios Papadopoulos, et al.
Pubblicazione: (2025)

The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort
di: Rosario Vasta, et al.
Pubblicazione: (2025)

Comprehensive Analysis of Sex Differences in Amyotrophic Lateral Sclerosis Prognosis and Disease Progression
di: Liangping Zhang, et al.
Pubblicazione: (2024)

Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
di: Marta Mascareñas‐García, et al.
Pubblicazione: (2026)

Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study
di: Luyi Zhu, et al.
Pubblicazione: (2024)

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex
di: J. Pansieri, et al.
Pubblicazione: (2025)

Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis
di: Maurizio Grassano, et al.
Pubblicazione: (2024)

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis
di: Federico Ranieri, et al.
Pubblicazione: (2025)

Reply to “Comprehensive Analysis of Sex Differences in Amyotrophic Lateral Sclerosis Prognosis and Disease Progression”
di: Maurizio Grassano, et al.
Pubblicazione: (2024)

Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis
di: Cato E. A. Corsten, et al.
Pubblicazione: (2026)

Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis
di: Giulio Disanto, et al.
Pubblicazione: (2025)

HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis
di: Stephan Neidhart, et al.
Pubblicazione: (2024)

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles
di: Hadia Nadeem
Pubblicazione: (2026)

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles
di: Christos V. Chalitsios, et al.
Pubblicazione: (2025)

DNA Methylation in the Anti‐Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis
di: Antonino Giordano, et al.
Pubblicazione: (2024)